| HS Code | 962970 |
| Product Name | BOC-L-Phenylalaninol |
| Cas Number | 66605-57-0 |
| Molecular Formula | C14H21NO3 |
| Molecular Weight | 251.32 g/mol |
| Iupac Name | tert-butyl N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]carbamate |
| Synonyms | (S)-2-(Boc-amino)-3-phenylpropan-1-ol; N-Boc-L-phenylalaninol; Boc-Phe-ol |
| Appearance | White to off-white crystalline solid |
| Melting Point | 94-98 °C |
| Boiling Point | 427.2 °C (predicted at 760 mmHg) |
| Optical Rotation | [α]20/D = -22° (c=1, methanol) |
| Storage Conditions | Store sealed at 2-8 °C, protected from moisture |
| Solubility | Soluble in methanol, ethanol, dichloromethane and chloroform; sparingly soluble in water |
| Smiles | CC(C)(C)OC(=O)N[C@@H](CO)CC1=CC=CC=C1 |
As an accredited BOC-L-Phenylalaninol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | BOC-L-Phenylalaninol is supplied in a sealed glass bottle under nitrogen, with quantities of 5 g or 25 g available. |
| Container Loading (20′ FCL) | BOC-L-Phenylalaninol loaded in 20′ FCL container, secured drums, moisture-proof packaging, labeled correctly, compliant documentation, safe transport. |
| Shipping | BOC-L-Phenylalaninol is shipped as a chemically stable solid, packaged in airtight, moisture-resistant vials. To maintain integrity, transport under cryogenic conditions using dry ice or cold packs within insulated containers. Ensure compliance with local hazardous material regulations, avoiding exposure to heat, light, and humidity during transit to preserve purity. |
| Storage | Store BOC-L-Phenylalaninol in a tightly sealed container, protected from light and moisture, in a cool, dry, well-ventilated area. Keep away from strong oxidizing agents and ignition sources. For prolonged stability, storage under inert gas such as nitrogen is recommended. Always consult the Safety Data Sheet for specific handling requirements. |
| Shelf Life | Store in a cool, dry place, tightly sealed. Stable for at least two years under recommended conditions. |
tert-Butyl (S)-(1-hydroxy-3-phenylpropan-2-yl)carbamate, molecular weight 251.32 g/mol, is charged at 1.0–1.2 molar equivalents relative to the terminal carboxylate component in solution-phase coupling trains that construct hydroxyethylamine peptidomimetic scaffolds. Materials destined for API intermediate use are released against ICH Q7 Section 7.3 identity testing and ICH M7 hazard assessment for process-related impurities; residual water is controlled by Karl Fischer titration per USP <921> to 0.1% w/w before charging. The downstream process on multi-kilogram scale consists of dissolving the carbamate in anhydrous tetrahydrofuran at 8–12 L/kg, adding triethylamine at 1.3–1.5 eq, and converting the primary alcohol to the mesylate with methanesulfonyl chloride at −5 to 0°C over 30–45 min in a glass-lined reactor with a jacket outlet temperature not exceeding −10°C. The resulting sulfonate is displaced with a primary or secondary amine nucleophile in dimethylformamide at 60–65°C, followed by aqueous bicarbonate quench, phase cut, and solvent exchange into ethyl acetate. Terminal product types from this route include hydroxyethylamine transition-state analogs, sulfonamide isosteres, and protected amino epoxides that enter downstream protease inhibitor synthesis. The operational boundary is narrow: methanesulfonate intermediates undergo elimination above 25°C, and residual water above 0.2% w/w reduces displacement selectivity by forming diol by-products.
The oxidation train is designed around the liability of N-Boc-L-phenylalaninal, which racemizes under mildly basic aqueous quench and decomposes during prolonged storage. ICH Q3C Option 2 solvent limits constrain the post-reaction extractive workup: residual dichloromethane in the aldehyde-bearing organic stream must remain below 600 ppm after vacuum solvent exchange because the aldehyde is typically carried forward without drying. Dess-Martin periodinane is charged at 1.2–1.5 molar equivalents relative to the alcohol, with the slurry metered over 20–30 min into a dichloromethane solution at 0–5°C. The oxidation exotherm is controlled by adding the oxidant in thirds; in a 50 L glass-lined vessel, cooling capacity of 0.4–0.6 kW is usually sufficient only when the feed is pre-chilled to 0°C. After 60–90 min, the mixture is quenched into saturated sodium bicarbonate and sodium thiosulfate at 5–10°C, with phase pH maintained at 6.8–7.2 to suppress benzyl-position epimerization. The resulting N-Boc-L-phenylalaninal is used immediately in reductive amination or Grignard addition without isolation. Downstream products include chiral β-amino alcohols, non-proteinogenic amino alcohols, and transition-state mimic intermediates for protease and renin inhibitor programs. Published batch data for this specific oxidation at tonne scale is limited; development teams therefore maintain the aldehyde as an uncertified intermediate and avoid storage of the neat oil.
| Control point | Reference method / standard | Typical acceptance limit |
|---|---|---|
| Water content before coupling | USP <921> / ISO 760 | ≤ 0.1% w/w |
| Residual dichloromethane after oxidation workup | ICH Q3C Class 2 | ≤ 600 ppm |
| Residual tetrahydrofuran after solvent exchange | ICH Q3C Class 2 | ≤ 720 ppm |
| Enantiomeric purity of chiral aldehyde intermediate | Chiral HPLC, area normalization | ≥ 98.0% e.e. |
| Benzyl-position epimerization during carbonyldiimidazole cyclization | Chiral GC, area normalization | ≤ 0.5% area |
| Long-term storage temperature | Internal stability protocol | ≤ −20°C |
Because the carbamate protecting group is stable to mild hydride delivery but labile under strong Lewis acid conditions, the compound is supplied to asymmetric catalysis groups as a precursor to the corresponding free amino alcohol rather than as a ready-made ligand. In ligand campaigns, BOC-L-Phenylalaninol is deprotected with 4.0 M hydrogen chloride in 1,4-dioxane at 20–25°C for 2–3 h, after which the liberated (S)-2-amino-3-phenyl-1-propanol is neutralized and azeotropically dried. The subsequent oxazaborolidine formation uses borane–tetrahydrofuran complex at 1.0–1.05 molar equivalents relative to the amino alcohol in THF at 0–5°C, with water content below 50 ppm by Karl Fischer titration per ISO 760. Process control is anchored to ISO 9001:2015 clause 8.4 for externally provided raw materials and to the specific reduction campaign’s analytical protocol; the in situ catalyst is not isolated, so batch-to-batch variance is tracked by enantiomeric excess of the reduced ketone substrate by chiral HPLC. The ligand is employed at 5–10 mol% catalyst loading for enantioselective ketone reductions. Terminal finished product types from this application are enantiomerically enriched secondary alcohols, chiral intermediates for active pharmaceutical ingredients, and hydroxyl-bearing building blocks for further acylation.
When the target is a chiral oxazolidin-2-one auxiliary, the carbamate group of BOC-L-Phenylalaninol is removed before cyclization because direct cyclization of the N-Boc amino alcohol with carbonyldiimidazole yields a complex mixture of carbonates and isocyanates. The downstream production route therefore begins with acidic deprotection in methanolic hydrogen chloride at 10–15°C, followed by solvent exchange to toluene and azeotropic drying to water below 0.05% w/w. The free amino alcohol is cyclized with 1.1–1.3 molar equivalents of N,N′-carbonyldiimidazole in anhydrous dichloromethane at 0–10°C. After 2 h, the mixture is washed with cold aqueous sodium chloride, concentrated under reduced pressure at 30–35°C, and crystallized from ethyl acetate/n-heptane. Residual solvent levels are controlled to ICH Q3C limits: dichloromethane 600 ppm, azeotropic toluene 890 ppm. The resulting (S)-4-benzyl-2-oxazolidinone is employed as a chiral auxiliary in asymmetric alkylation, aldol addition, and conjugate addition reactions. Terminal finished product types are chiral auxiliaries for medicinal chemistry route scouting, auxiliary-bearing intermediates, and enantiomerically enriched carboxylic acid derivatives after auxiliary cleavage. Process development groups monitor auxiliary integrity by chiral gas chromatography; epimerization at the benzylic position is kept below 0.5% area during the cyclization.
The compound is also released as a custom synthesis building block for contract research and preclinical API manufacturing campaigns in which the downstream chemistry has not yet been fixed. In this application, the operable standards are the analytical release profile defined by the sponsor and the manufacturing requirements of ICH Q7 Chapters 5, 6, and 7 for process equipment, documentation, and materials management. The carbamate is typically charged at 1.0 molar equivalent relative to the first synthetic transformation, but the addition ratio varies with the route: reductions, Mitsunobu activations, and sulfonylation steps may require from 1.0 to 1.5 molar equivalents of the substrate depending on the stoichiometry of the activating reagent. Downstream production equipment includes jacketed parallel reactors with independent temperature zones, in situ ReactIR probes for monitoring carbamate disappearance, and automated flash chromatography units for isolating intermediates. Terminal finished product types span drug candidate libraries, purified reference standards, and multi-hundred-gram accelerated stability batches. The boundary conditions are strict: the material must be stored at −20°C under nitrogen for long-term stability, and exposure to ambient relative humidity above 60% for more than 4 h causes surface hydration that alters weighing accuracy and subsequent coupling stoichiometry.
Competitive BOC-L-Phenylalaninol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
BOC-L-Phenylalaninol, also designated N-Boc-L-phenylalaninol or (S)-tert-butyl (1-hydroxy-3-phenylpropan-2-yl)carbamate, is a single-enantiomer protected amino alcohol with CAS number 66605-57-0, molecular formula C14H21NO3, and relative molecular mass 251.32 g/mol. It is supplied as a white to off-white crystalline powder with a lot-specific melting range generally reported between 94 °C and 98 °C. The tert-butoxycarbonyl group blocks the primary amine, leaving the primary hydroxyl available for selective esterification, sulfonate formation, oxidation, or displacement. Catalogue grades differ mainly by analytical documentation and purity tier. A routine research grade is released against HPLC purity not less than 98.0%; higher-tier lots may be released with HPLC purity not less than 99.0%, enantiomeric excess not less than 99.5%, and a custom certificate of analysis for GMP starting material use. Product model designations commonly include the synonym Boc-Phe-ol, but ordering should identify the L-stereochemistry explicitly because the D-enantiomer and racemic variant are separately catalogued. The product is not a finished pharmaceutical substance, and no monograph for this protected amino alcohol exists in USP–NF or Ph. Eur. Its functional value is retention of the L-configuration while the C-terminal side chain is transformed.
Enantiomeric purity is controlled by chiral HPLC, not by optical rotation alone. Typical release documentation sets enantiomeric excess at ≥ 99.0%, using a polysaccharide-based chiral stationary phase and the D-enantiomer as the reference standard. The acceptance window for specific rotation under USP <781> is commonly −27° to −31° in methanol at 20 °C and c=1, but this value is influenced by residual water and solvent composition. HPLC area-normalisation purity is usually set at ≥ 98.0% with detection at 210 nm or 254 nm, because the phenyl chromophore gives strong absorbance and the carbamate absorbs at lower wavelengths. Karl Fischer coulometric titration limits water to ≤ 0.5%; residual moisture is a critical parameter because the alcohol is often used with sulfonyl chlorides, oxalyl chloride, or lithium aluminium hydride. Residual solvents are assigned against ICH Q3C by headspace GC-FID. Loss on drying at 60 °C under vacuum may be used as a supporting test, but for water-sensitive downstream reactions the coulometric water value is the main release criterion. Chiral method suitability often requires that a solution spiked with 0.5% D-enantiomer gives baseline separation from the L-form; if the peak area of the D-enantiomer is below 0.05%, the result is reported as not detected. The table below summarises typical release criteria and analytical methods from supplier dossiers; it does not replace a lot-specific certificate of analysis.
| Quality attribute | Typical acceptance criterion | Analytical technique |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual inspection |
| HPLC purity | ≥ 98.0% area | Reverse-phase C18, acetonitrile/water, UV at 210 nm |
| Enantiomeric excess | ≥ 99.0% | Chiral HPLC, polysaccharide-based CSP, D-enantiomer reference |
| Specific rotation | −27° to −31° | USP <781>, methanol, 20 °C, c=1 |
| Water content | ≤ 0.5% | Karl Fischer coulometric titration |
| Residue on ignition | ≤ 0.1% | Sulfated ash determination |
| Residual solvents | Class 2/3 limits per ICH Q3C | Headspace GC-FID |
At pilot scale, the compound is charged into glass-lined reactors for conversion to the methanesulfonate or tosylate. Selective O-activation is performed with methanesulfonyl chloride at −10 °C to 0 °C in dichloromethane or tetrahydrofuran. The internal temperature during reagent addition is a processing window of roughly 5 °C; higher exotherms can precipitate triethylamine hydrochloride and increase agitator torque. A tertiary amine base is used at 2.0–2.2 equivalents to neutralise the liberated HCl, while methanesulfonyl chloride is held at 1.0–1.05 equivalents to limit sulfone formation and aggressive quench exotherms. After the reaction, the batch is quenched into cold water at 0–5 °C, washed with sodium bicarbonate to pH 7.5–8.0, and concentrated below 30 °C. If the free alcohol is not pre-dried at relative humidity above 60%, water reacts with sulfonyl chloride and reduces the available reagent. The Boc protecting group remains intact during sulfonylation but is rapidly removed by trifluoroacetic acid or HCl; therefore, acid deprotection is positioned after O-functionalisation. Storage of solid material in tightly closed containers at 2–8 °C with nitrogen purge after each opening is standard, because moisture ingress can produce caked solids and shift optical rotation through partial solvate formation. Published production-scale yield data for this specific configuration is limited, and process descriptions vary with the downstream reaction sequence.
The Boc group is removed by acidolysis, whereas the corresponding N-Cbz-L-phenylalaninol requires palladium-catalysed hydrogenation in ethanol or ethyl acetate. If the downstream intermediate contains alkenes, nitriles, nitro groups, or sulfur-bearing residues, hydrogenolysis can cause reduction or catalyst poisoning; in such cases BOC-L-Phenylalaninol is preferred. Acidolysis is carried out with 20% trifluoroacetic acid in dichloromethane at 0–25 °C or with 4 M HCl in 1,4-dioxane. The liberated tert-butyl cation must be scavenged with triisopropylsilane to prevent alkylation of electron-rich aromatic rings. If the substrate contains acid-labile acetal, silyl ether, or glycosidic bonds, the hydrogenolytic Cbz route may be preferred because it is pH-neutral. This difference in deprotection chemistry is a primary selection criterion and is more important than melting-point or chromatographic differences. BOC-L-Phenylalaninol also differs from N-Boc-L-phenylalanine in that the alcohol does not participate directly in amide coupling; this avoids carboxyl activation steps when a reduced amide or hydroxyethylamine motif is the synthetic target. The alcohol can be oxidised to N-Boc-L-phenylalaninal for reductive amination or converted to a sulfonate electrophile for nucleophilic displacement. In both cases, the Boc group provides temporary amine masking without a hydrogenation step.
Compared with unprotected L-phenylalaninol, the Boc-protected derivative has a higher molecular mass and a blocked primary amine. This blocking suppresses intramolecular aziridine formation when the hydroxyl is converted to a tosylate or mesylate; in the unprotected amino alcohol, the free amine can displace the leaving group and consume the intermediate. Chiral HPLC separation of BOC-L-Phenylalaninol from its D-enantiomer is typically achieved on a 250 mm × 4.6 mm polysaccharide carbamate column with 5 µm particles and an alcohol-hydrocarbon or polar organic mobile phase. Column temperature is usually held at 25 °C for repeatability; injection mass is limited to maintain baseline resolution. Detection at 210 nm can be affected by mobile-phase background, so 254 nm is used when the impurity profile is dominated by phenyl-containing species. The corresponding N-Boc-L-phenylalaninal is a more reactive intermediate in reductive aminations but is less stable on storage and more prone to base-catalysed racemisation. The alcohol form is therefore selected for transport and multi-step campaigns where the aldehyde is generated as a transient intermediate. Solubility of the alcohol in dichloromethane, tetrahydrofuran, ethyl acetate, and methanol is sufficient for common reaction concentrations of 0.1–0.5 M; heptane and other aliphatic hydrocarbons are used as antisolvents for crystallisation. Water solubility is limited, and aqueous workup losses increase if the organic phase is dispersed as fine droplets rather than a continuous layer.
The following comparison is based on standard protecting-group chemistry and supplier technical dossiers, not on a single certificate of analysis.
| Attribute | BOC-L-Phenylalaninol | N-Cbz-L-phenylalaninol | Unprotected L-Phenylalaninol |
|---|---|---|---|
| Molecular mass | 251.32 g/mol | 285.34 g/mol | 151.21 g/mol |
| Protection | Acid-labile Boc | Hydrogenolytic Cbz | None |
| Typical deprotection | 20% TFA in dichloromethane or 4 M HCl in dioxane | H2/Pd-C in ethanol or ethyl acetate | Not applicable |
| Primary side reaction to control | tert-butyl cation alkylation; add triisopropylsilane | Alkene or nitro reduction; sulfur catalyst poisoning | Aziridine formation upon sulfonylation |
| Typical chiral purity release | ≥ 99.0% ee | ≥ 99.0% ee | ≥ 98.0% ee |
| Preferred when | Substrate contains reducible groups; acidolysis is acceptable | Substrate contains acid-labile groups; neutral deprotection required | Free amine is required without a deprotection step |
Continuous flow processing of BOC-L-Phenylalaninol solutions is feasible when the feed is filtered through a 0.45 µm membrane to protect microreactor channels from crystalline fines. In a flow oxidation using Dess-Martin periodinane or trichloroisocyanuric acid-TEMPO, the residence time is governed by the alcohol-to-oxidant ratio and the back-pressure regulator setting; if the back-pressure is below 1.0 bar, gas evolution from dissolved by-products can create slug flow and reduce conversion. The reaction stream is quenched in-line with aqueous sodium thiosulfate to destroy excess oxidant before extraction; a pH of 7.5–8.0 is maintained during quench to avoid premature Boc cleavage. Process analytical technology may include near-infrared monitoring of the hydroxyl O-H stretch at approximately 3500 cm−1, but calibration requires a representative set of process mixtures because water and solvent bands overlap. Batch-to-batch variance in residual water and solvent composition has a larger effect on reaction conversion than minor differences in particle size; this is why release criteria prioritise water and residual solvent limits. In automated solid-charging systems, caked material with poor flow can create dosing errors; if the powder has been stored under humid conditions, it should be dried under vacuum at 40 °C before use, but only if the certificate of analysis permits thermal drying for the intended application.
Supply-chain documentation for GMP-compliant use includes residual solvent testing under ICH Q3C, elemental impurities under ICH Q3D when the material is intended for late-phase API synthesis, and optical rotation under USP <781>. No pharmacopoeial monograph is published for BOC-L-Phenylalaninol in USP–NF or Ph. Eur.; therefore, compendial methods do not apply directly, and release specifications are buyer-specific. The material is often classified under customs tariff codes for amino-alcohol derivatives; shipping is generally regulated by the residual solvent profile rather than the solid itself. Safety data sheets from major suppliers commonly assign no GHS hazard classification, but this is not universal and must be verified for the actual lot. For research quantities, the product is packed under nitrogen in glass or fluoropolymer bottles; for larger quantities, double polyethylene liners inside sealed drums are used to limit moisture and oxygen ingress. Operators should use local exhaust ventilation when transferring dry powder, because fine organic solids can generate combustible dust clouds under conditions of sufficient ignition energy and particle size distribution.